[Pharmwaste] FW: Drug Companies Targeted Under RCRA

Stevan Gressitt gressitt at uninets.net
Mon Jan 9 20:44:36 EST 2006 

FYI.

 

Stevan Gressitt, M.D.

Ensure Proper Waste Management
Recalled, Rejected and Expired Pharmaceuticals 

An audioconference 
Thursday, Jan. 19, 2006 * 1:30 p.m. - 3:00 p.m. EST

Register
<http://www.fdanews.com/wbi/conferences/wastemanagement.html?s=9116&p=061MML
>  now!

Avoid $32,500/day fines, criminal suits ... and jail time! 

Ever think of your pharmaceuticals as hazardous waste? EPA does - and in the
wake of massive recalls like Vioxx and Bextra, the agency is cracking down,
holding drugmakers accountable for cradle-to-grave compliance with the
Resource Conservation and Recovery Act (RCRA). In fact, drug disposal is
emerging as a red-hot environmental issue.

But it's not just EPA you need to worry about. DEA, DOT, and states'
attorneys general are in the hunt, too - and everyone from managers on up
could be personally liable for violations ... with no statute of limitation.


Make sure your waste management SOPs don't put you at risk: register
<http://www.fdanews.com/wbi/conferences/wastemanagement.html?s=9116&p=061MML
>  now! 

In 90 minutes, pharmaceutical waste experts Richard Verch and Charlotte
Smith translate RCRA's non-industry-specific requirements into clear
guidance on how to discard recalled, rejected and expired pharmaceuticals. 

You'll gain a comprehensive perspective on what state and federal
requirements you must meet, and how to identify, label, transport and manage
waste pharmaceuticals generated during manufacturing processes. You'll learn
how to defuse problems when products are removed from the market, plus ...
you'll discover what controls are needed to avoid violations on bulk or
finished-dose drugs. 

Don't wait! Bring supply chain policies and procedures into compliance
BEFORE violations cost you devastating fines and personal liability.

Register
<http://www.fdanews.com/wbi/conferences/wastemanagement.html?s=9116&p=061MML
>  now to learn:

*	What drugs are on RCRA's lists of hazardous wastes 
*	How to tell if nonlisted pharmaceuticals meet other EPA hazardous
waste criteria 
*	Today's top 5 disposal pitfalls - and how to avoid them 
*	How to meet DEA requirements for handling, waste transfer, disposal
and the "witnessed burn" process 
*	What you MUST know about transporting waste pharmaceuticals - even
when they're not classified as hazardous 
*	How to steer clear of state regulations (many are tougher than
federal ones!) 
*	Best management practices for disposing of nonhazardous drugs 
*	And more 

Meet Your Instructors 
Richard Verch founded Strong Environmental in 1993 and since then, the
company's Pharmaceutical Services division has become the leading provider
of special destruction services to the pharmaceutical industry. Richard is
an engineer, a 10-year master level CHMM, as well as an REM and CEA. He has
worked in the environmental industry since 1982 where, at Air Techniques, he
performed EPA source emission testing and elaborate air filtration
design/build systems. He also worked for Fichtner GmBH, consulting and
engineering MSW and incineration designs. Richard participates and serves on
many industry related groups, boards, associations and committees.

Charlotte Smith is president of PharmEcology Associates, LLC, a firm she
founded in 2000 to help the healthcare industry reduce and manage
pharmaceutical waste. She co-founded Capital Returns, a nationally known
pharmaceutical reverse distributor in 1991, and for 10 years served as
president and chief regulatory adviser. In those positions, Charlotte
pioneered the application of the EPA's Resource Conservation and Recovery
Act (RCRA) regulations to pharmaceutical waste streams within the reverse
distribution industry and developed management systems to assist healthcare
facilities in reducing and managing pharmaceutical waste. She is a
registered pharmacist and serves on the CDC's NIOSH Hazardous Drug Working
Group.

Register
<http://www.fdanews.com/wbi/conferences/wastemanagement.html?s=9116&p=061MML
>  now! 

Who Will Benefit
The audioconference is a must for informing staff at all levels of their
liability under RCRA, especially:

*	Regulatory personnel 
*	Risk managers 
*	Corporate officers 
*	Compliance personnel 


Audioconference Details


Date:

Thursday, Jan. 19, 2006


Location:

Your office or conference room (no need to travel!)


Time:

1:30 p.m. 12:30 p.m. 11:30 a.m. 10:30 a.m. 6:30 p.m.

-
-
-
-
-

3:00 p.m. EST
2:00 p.m. CST
1:00 p.m. MST
Noon PST
8:00 p.m. GMT

 


Gather your team for maximum benefit! Your investment is for one dial-in.

Interested in registering multiple sites?
Call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally
to learn about our special multisite discount.


Four Cost-Effective Tuition Options
All participants of the live session are eligible to receive a certificate
of attendance.


  <http://www.fdanews.com/images/ads/StarburstR.gif> 

1.	Audioconference PLUS Audio CD and Transcript: $590 Best Value! Save
$200!
You'll have access to one dial-in for the live 90-minute audioconference for
unlimited participants! You'll also receive all presentation materials and
the opportunity to ask questions by phone and email, PLUS an audio CD and
written transcript of the entire session.
2.	Audioconference Only: $395 
You'll have access to one dial-in for the live 90-minute audioconference for
unlimited participants! You'll also receive all presentation materials and
the opportunity to ask questions by phone and email. 
3.	Audio CD and Transcript Only: $395 (plus shipping and handling)
You'll receive an audio CD, written transcript of the entire 90-minute
audioconference, including the Q&A period, and all presentation materials
four weeks after the session. 
4.	24/7 ENCORE(tm) Audio Presentation: $395 
You'll have access to one dial-in for an archived recording of the entire
90-minute audioconference, including the Q&A period, for unlimited
participants. You can dial in any time of day or night for three weeks, from
Jan. 23 - Feb. 10, 2006. You'll also receive all presentation materials. 

Three Easy Ways to Register
Please mention priority code 061MML when registering.

1.	  <http://www.fdanews.com/images/ads/Mouse.gif> Enroll online.
<http://www.fdanews.com/wbi/conferences/wastemanagement.html?s=9116&p=061MML
>  
2.	  <http://www.fdanews.com/images/ads/Phone.gif> Call +1 (703)
538-7600 or toll free (888) 838-5578. Use your American Express, Visa or
MasterCard. 
3.	  <http://www.fdanews.com/images/ads/Env.gif> Mail your check to:
FDAnews, 300 N. Washington St., Suite 200 Falls Church, VA 22046-3431. 

Satisfaction Guaranteed
You must be 100% satisfied with this learning opportunity or we'll refund
your entire tuition or extend a credit to a future FDAnews audioconference.


The email address on file is hunterj at cder.fda.gov.
Click
<http://www.fdanews.com/cgi-bin/udt/mlm3.unsub?cid=fdanews&uid=8042837&lid=p
romo&e=hunterj at cder.fda.gov>  here to be removed from this mailing list.

-----------------------
FDAnews, 300 N. Washington St., Suite 200, Falls Church, VA 22046-3431

  <http://www.fdanews.com/images/eletterbtn.gif?fdanews.9116.8042837> 

-------------- next part --------------
An HTML attachment was scrubbed...
URL: http://lists.dep.state.fl.us/pipermail/pharmwaste/attachments/20060109/ad2746d4/attachment-0001.htm

More information about the Pharmwaste mailing list